Literature DB >> 27191492

Drug development: A healthy pipeline.

Branwen Morgan.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27191492     DOI: 10.1038/533S116a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women.

Authors:  Shin Fukudo; Yoshikazu Kinoshita; Toshikatsu Okumura; Motoko Ida; Hiraku Akiho; Yoshihiro Nakashima; Akito Nishida; Ken Haruma
Journal:  Gastroenterology       Date:  2015-11-06       Impact factor: 22.682

  1 in total
  1 in total

1.  Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.

Authors:  Sara Botschuijver; Sophie A van Diest; Isabelle A M van Thiel; Rafael S Saia; Anne S Strik; Zhumei Yu; Daniele Maria-Ferreira; Olaf Welting; Daniel Keszthelyi; Gary Jennings; Sigrid E M Heinsbroek; Ronald P Oude Elferink; Frank H J Schuren; Wouter J de Jonge; René M van den Wijngaard
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.